Ara
Toplam kayıt 266, listelenen: 261-266
Long-Term Outcome of Patients with Spinal Myxopapillary Ependymoma: Treatment Results from the Md Anderson Cancer Center and Institutions from the Rare Cancer Network
(Oxford Univ Press, 2015)
Background. Spinal myxopapillary ependymomas (MPEs) are slowly growing ependymal gliomas with preferential manifestation in young adults. The aim of this study was to assess the outcome of patients with MPE treated with ...
Generic Imatinib Mesylate Is As Effective As Original Glivec In The Clinical Management Of Cml
(Akad Doktorlar Yayınevi, 2015)
Unsustainable drug prices in chronic myeloid leukemia (CML) and cancer may be causing harm to patients. The aim of this multi-center study is to assess the efficacy of generic imatinib mesylate (IM) over Glivec in terms ...
Review of Current Status of Radiotherapy Facilities And Assessment of Required Time For Radiotherapy Delivery Workflow in Turkey: On Behalf of Turkish Society For Radiation Oncology
(Akad Doktorlar Yayınevi, 2015)
The aim this study is to evaluate current status and workload of radiotherapy (RT) centers in Turkey, by assessing time and staff required during core treatment procedures in patients with different tumor sites. A survey ...
Safety and Efficacy of Ankaferd Hemostat (Abs) in the Chemotherapy-Induced Oral Mucositis
(Akad Doktorlar Yayınevi, 2015)
Oral mucositis, characterized by ulcerative lesions in the oral mucosa of patients undergoing chemotherapy, is currently considered to be the most severe complication of anti-cancer therapy which is affecting 40-80% of ...
Evidence-Based Recommendations For Genetic Diagnosis Of Familial Mediterranean Fever
(BMJ, 2015)
Familial Mediterranean fever (FMF) is a disease of early onset which can lead to significant morbidity. In 2012, Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched with the aim of optimising ...
European Protocols For The Diagnosis And Initial Treatment Of Interstitial Lung Disease In Children
(BMJ, 2015)
Interstitial lung disease in children (chILD) is rare, and most centres will only see a few cases/year. There are numerous possible underlying diagnoses, with specific and non-specific treatment possibilities. The chILD-EU ...